ZJYL Fundamental Analysis - JIN MEDICAL INTERNATIONAL LT

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to ZJYL. ZJYL was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of ZJYL get a neutral evaluation. Nothing too spectacular is happening here. ZJYL does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

ZJYL had positive earnings in the past year.

In the past year ZJYL has reported a negative cash flow from operations.

Each year in the past 5 years ZJYL has been profitable.

Of the past 5 years ZJYL 4 years had a positive operating cash flow.

1.2 Ratios

ZJYL's Return On Assets of 8.03% is amongst the best of the industry. ZJYL outperforms 90.37% of its industry peers.

ZJYL has a Return On Equity of 12.76%. This is amongst the best in the industry. ZJYL outperforms 89.30% of its industry peers.

With an excellent Return On Invested Capital value of 7.79%, ZJYL belongs to the best of the industry, outperforming 86.63% of the companies in the same industry.

ZJYL had an Average Return On Invested Capital over the past 3 years of 9.49%. This is in line with the industry average of 7.89%.

		Industry Rank	Sector Rank
ROA	8.03%
ROE	12.76%
ROIC	7.79%

ROA(3y)9.9%

ROA(5y)10.46%

ROE(3y)14.18%

ROE(5y)16.34%

ROIC(3y)9.49%

ROIC(5y)11.9%

1.3 Margins

Looking at the Profit Margin, with a value of 15.64%, ZJYL belongs to the top of the industry, outperforming 93.05% of the companies in the same industry.

ZJYL's Profit Margin has declined in the last couple of years.

ZJYL's Operating Margin of 15.48% is amongst the best of the industry. ZJYL outperforms 85.56% of its industry peers.

In the last couple of years the Operating Margin of ZJYL has declined.

ZJYL has a worse Gross Margin (40.43%) than 67.91% of its industry peers.

In the last couple of years the Gross Margin of ZJYL has grown nicely.

		Industry Rank	Sector Rank
OM	15.48%
PM (TTM)	15.64%
GM	40.43%

OM growth 3Y6.9%

OM growth 5Y-6.46%

PM growth 3Y7.26%

PM growth 5Y-2.67%

GM growth 3Y9.69%

GM growth 5Y1.86%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ZJYL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.

ZJYL has more shares outstanding than it did 1 year ago.

The number of shares outstanding for ZJYL has been reduced compared to 5 years ago.

The debt/assets ratio for ZJYL is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 6.03 indicates that ZJYL is not in any danger for bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 6.03, ZJYL belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.

ZJYL has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.39, ZJYL is in line with its industry, outperforming 44.92% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.39
Debt/FCF	N/A
Altman-Z	6.03

ROIC/WACC1.09

WACC7.17%

2.3 Liquidity

A Current Ratio of 2.50 indicates that ZJYL has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 2.50, ZJYL is in line with its industry, outperforming 47.59% of the companies in the same industry.

A Quick Ratio of 2.19 indicates that ZJYL has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 2.19, ZJYL is in line with its industry, outperforming 51.87% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.5
Quick Ratio	2.19

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.76% over the past year.

Measured over the past 5 years, ZJYL shows a small growth in Earnings Per Share. The EPS has been growing by 3.28% on average per year.

The Revenue has grown by 18.57% in the past year. This is quite good.

ZJYL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.90% yearly.

EPS 1Y (TTM)15.76%

EPS 3Y5.52%

EPS 5Y3.28%

EPS Q2Q%66.67%

Revenue 1Y (TTM)18.57%

Revenue growth 3Y4.22%

Revenue growth 5Y2.9%

Sales Q2Q%35.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 30.34, which means the current valuation is very expensive for ZJYL.

Based on the Price/Earnings ratio, ZJYL is valued a bit cheaper than the industry average as 71.12% of the companies are valued more expensively.

ZJYL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.35.

		Industry Rank	Sector Rank
PE	30.35
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZJYL is valued a bit cheaper than the industry average as 77.01% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	16.27

4.3 Compensation for Growth

The decent profitability rating of ZJYL may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)9.26

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ZJYL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

JIN MEDICAL INTERNATIONAL LT

NASDAQ:ZJYL (6/20/2025, 8:06:50 PM)

After market: 0.68 +0.07 (+12.04%)

0.6069

-0.1 (-13.79%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.64%

Inst Owner Change-47.52%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap95.01M

AnalystsN/A

Price TargetN/A

Short Float %0.94%

Short Ratio1.65

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	30.35
Fwd PE	N/A
P/S	4.04
P/FCF	N/A
P/OCF	N/A
P/B	3.3
P/tB	3.43
EV/EBITDA	16.27

EPS(TTM)0.02

EY3.3%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.01

FCFYN/A

OCF(TTM)-0.01

OCFYN/A

SpS0.15

BVpS0.18

TBVpS0.18

PEG (NY)N/A

PEG (5Y)9.26

Profitability

		Industry Rank	Sector Rank
ROA	8.03%
ROE	12.76%
ROCE	12.7%
ROIC	7.79%
ROICexc	23.55%
ROICexgc	25.79%
OM	15.48%
PM (TTM)	15.64%
GM	40.43%
FCFM	N/A

ROA(3y)9.9%

ROA(5y)10.46%

ROE(3y)14.18%

ROE(5y)16.34%

ROIC(3y)9.49%

ROIC(5y)11.9%

ROICexc(3y)22.47%

ROICexc(5y)22.7%

ROICexgc(3y)23.46%

ROICexgc(5y)23.49%

ROCE(3y)12.88%

ROCE(5y)15.84%

ROICexcg growth 3Y-2.39%

ROICexcg growth 5Y-7.19%

ROICexc growth 3Y-4.58%

ROICexc growth 5Y-8.54%

OM growth 3Y6.9%

OM growth 5Y-6.46%

PM growth 3Y7.26%

PM growth 5Y-2.67%

GM growth 3Y9.69%

GM growth 5Y1.86%

F-Score3

Asset Turnover0.51

Health

		Industry Rank	Sector Rank
Debt/Equity	0.39
Debt/FCF	N/A
Debt/EBITDA	2.84
Cap/Depr	324.82%
Cap/Sales	4.78%
Interest Coverage	15.2
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.5
Quick Ratio	2.19
Altman-Z	6.03

F-Score3

WACC7.17%

ROIC/WACC1.09

Cap/Depr(3y)128.78%

Cap/Depr(5y)88.37%

Cap/Sales(3y)1.86%

Cap/Sales(5y)1.33%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)15.76%

EPS 3Y5.52%

EPS 5Y3.28%

EPS Q2Q%66.67%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)18.57%

Revenue growth 3Y4.22%

Revenue growth 5Y2.9%

Sales Q2Q%35.29%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y26.9%

EBIT growth 3Y11.4%

EBIT growth 5Y-3.75%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-177.91%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-138.86%

OCF growth 3YN/A

OCF growth 5YN/A

JIN MEDICAL INTERNATIONAL LT (ZJYL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens